Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Oxygen rental payments

This article was originally published in The Gray Sheet

Executive Summary

Bill (S 3814) introduced Aug. 3 by Sen. Pat Roberts (R-Kan.) would kill a provision in the Deficit Reduction Act that stops rental payments to oxygen tank providers after 36 months. The targeted provision in the DRA would have transferred ownership of oxygen equipment to the beneficiary after 18 months of use; however, Invacare rallied members of Congress to extend payments 1("The Gray Sheet" Jan. 2, 2006, p. 12). "The Home Oxygen Patient Act of 2006" would ensure that CMS rents the equipment on behalf of beneficiaries for as long as they require it. Sen. Roberts states that giving patients ownership of the tanks is "an unreasonable burden and worry for seniors who are very ill." Companion legislation was introduced in the House in May...

You may also be interested in...

Invacare Rallies Ohio Republicans To Extend Medical Equipment Payments

Durable medical equipment (DME) maker Invacare successfully lobbied members of Congress to fight a last-minute Medicare budget provision that would have stopped rental payments to oxygen tank providers after 18 months of use

Novartis Targets Ten Indications For Cosentyx

The Swiss giant is hoping to get seven more approvals for its blockbuster immunology drug over the next 10 years.

Zydus Cadila Strides Ahead With NASH Filing In India

Cadila has filed for approval of saroglitazar for NASH in India. The drug, which could emerge as the first medicine for the indication if approved, is already being used by a million Indian patients for diabetic dyslipidemia and hypertriglyceridemia.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts